Published in J Clin Lab Anal on January 01, 1990
Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem (1998) 13.93
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett (1998) 2.61
Hepatobiliary complications of total parenteral nutrition. Gastroenterology (1993) 1.76
Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology (1994) 1.54
Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantation. Pediatr Transplant (1998) 1.41
Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine. J Pharmacol Exp Ther (1998) 1.39
Epstein-Barr virus-associated syndromes in immunosuppressed liver transplant recipients. Clinical profile and recognition on routine allograft biopsy. Am J Surg Pathol (1990) 1.31
Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg (1991) 1.27
Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation (1989) 1.15
Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg (1989) 1.10
Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology (1995) 1.08
Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol (1999) 1.01
Distinctive gene expression profiles associated with Hepatitis B virus x protein. Oncogene (2001) 1.00
Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology (1987) 0.99
Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta (2001) 0.97
Thromboangiitis obliterans (Buerger's disease) and smokeless tobacco. Arthritis Rheum (1987) 0.96
Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci (1992) 0.93
Immunohistochemical characterization of lymphocytes in uninflamed ventricular myocardium. Implications for myocarditis. Arch Pathol Lab Med (1985) 0.92
Hepatocarcinoma in a child with the Alagille syndrome. Am J Dis Child (1987) 0.91
Fulminant hepatic failure with massive necrosis as a result of hepatitis A infection. J Clin Gastroenterol (1993) 0.91
Treatment of mammalian bite wounds of the maxillofacial region. J Oral Maxillofac Surg (1993) 0.90
A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg (1992) 0.90
Rapid identification of cytomegalovirus in liver allograft biopsies by in situ hybridization. Am J Surg Pathol (1988) 0.90
Biochemical and functional effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the heart of female rats. Toxicol Appl Pharmacol (1988) 0.90
Syndrome of multiple bowel perforations in liver transplant recipients. Am J Surg (1991) 0.90
Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus. Occup Environ Med (2004) 0.89
Neural patterns in inflammatory bowel disease: an immunohistochemical survey. Mod Pathol (1990) 0.87
Determination of 5-fluorouracil in human plasma by a simple and sensitive reversed-phase HPLC method. J Pharm Biomed Anal (1996) 0.87
Successful application of extracorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol (1993) 0.86
Cytochrome c: ion binding and redox properties. Studies on ferri and ferro forms of horse, bovine, and tuna cytochrome c. J Biol Chem (1988) 0.85
Malignant fibrous histiocytoma presenting in the right mandibular alveolar ridge and left lung: report of a case. J Oral Maxillofac Surg (1987) 0.84
Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol (1990) 0.84
Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol (1991) 0.84
Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child (1991) 0.84
Identification of cytidine diphosphodiesters in erythrocytes from a patient with pyrimidine nucleotidase deficiency. Blood (1984) 0.84
An unusual case of choledochal cyst causing hepatic failure requiring orthotopic liver transplantation. J Pediatr Surg (1992) 0.83
Disseminated Trichosporon beigelii infection after orthotopic liver transplantation. Am J Clin Pathol (1989) 0.83
A proposed role for silicates and protein in the proliferative effects of saccharin on the male rat urothelium. Carcinogenesis (1991) 0.83
Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J Pediatr (1995) 0.83
Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc (1991) 0.82
Circulating insulin-like growth factor (IGF)-I and IGF binding proteins -1 and -3 and placental development in the guinea-pig. Placenta (2002) 0.82
Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease. Am J Gastroenterol (1988) 0.81
Coumarin-induced hepatic necrosis. Am J Gastroenterol (1997) 0.80
Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes. Pediatr Nephrol (1993) 0.80
The impact of extended preservation on clinical liver transplantation. Transplantation (1990) 0.80
Successful prophylaxis of cytomegalovirus disease after primary CMV exposure in liver transplant recipients. Transplantation (1991) 0.79
31P NMR study of erythrocytes from a patient with hereditary pyrimidine-5'-nucleotidase deficiency. Proc Natl Acad Sci U S A (1983) 0.79
Fungal infections in liver allograft recipients. Transplant Proc (1991) 0.79
Reduction in mammary tumorigenesis in the rat by cabbage and cabbage residue. Carcinogenesis (1990) 0.79
Synthesis of certain [6:5:6] linear tricyclic nucleosides as potential antitumor agents. J Med Chem (1980) 0.79
Liver transplantation at the University of Nebraska Medical Center from 1985 to 1992. Clin Transpl (1992) 0.79
Multiple forms of rat liver L-asparagine synthetase. Biochem Biophys Res Commun (1979) 0.79
The use of iodotrimethylsilane in nucleosidation procedure. Nucleic Acids Res (1980) 0.78
Computed tomography and magnetic resonance imaging of cervical metastasis. Otolaryngol Head Neck Surg (1989) 0.78
Hepatic retransplantation: University of Nebraska Medical Center experience. Clin Transplant (1992) 0.78
Spinal cord compression secondary to Gaucher's disease. Surg Neurol (1984) 0.78
Hepatic ultrastructural changes induced by the toxin microcystin-LR (MCLR) in mice. J Environ Pathol Toxicol Oncol (1994) 0.78
Donor selection for orthotopic liver transplantation: lack of an effect of gender or cytomegalovirus (CMV) status. Transplant Proc (1990) 0.78
Heterotopic liver of the jejunum. Report of a case and a review. J Clin Gastroenterol (1989) 0.78
Orthotopic liver transplantation for graft-versus-host disease following bone marrow transplantation. Gastroenterology (1990) 0.78
gamma-Aminobutyric acid localization and function as modulator of cholinergic neurotransmission in rat antral mucosal/submucosal fragments. Gastroenterology (1991) 0.78
Efficient pyridinylmethyl functionalization: synthesis of 10, 10-Bis[(2-fluoro-4-pyridinyl)methyl]-9(10H)-anthracenone (DMP 543), an acetylcholine release enhancing agent. J Org Chem (2000) 0.77
Altered placental structure induced by maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the mother? Placenta (2001) 0.77
Treatment of valproic acid-associated hepatic failure with orthotopic liver transplantation. Ann Pharmacother (1992) 0.77
Sources of increased serum potassium following reperfusion of liver allografts. Transplant Proc (1987) 0.76
Kinetic mechanism of beef pancreatic L-asparagine synthetase. Biochemistry (1981) 0.76
Histopathologic evaluation of primary intestinal transplant recipients at autopsy: a single-center experience. Transplant Proc (2000) 0.75
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology (1999) 0.75
Bronchoalveolar lavage in liver transplant patients. Acta Cytol (1989) 0.75
Filtration of platelet-poor plasma specimens yields platelet-free plasma. Application for batch analysis of beta-thromboglobulin and platelet factor 4. Am J Clin Pathol (1990) 0.75
Synthesis and antileukemic activities of furanyl, pyranyl, and ribosyl derivatives of 4-(3,3-dimethyl-1-triazeno)imidazole-5-carboxamide and 3-(3,3-dimethyl-1-triazeno)pyrazole-4-carboxamide. J Med Chem (1979) 0.75
Plasma laudanosine levels in patients given atracurium during liver transplantation. Anesth Analg (1993) 0.75
Thymic lesions in fatal infectious mononucleosis. Clin Immunol Immunopathol (1987) 0.75
Ganciclovir therapy for cytomegalovirus disease in liver transplant recipients. Transplant Proc (1991) 0.75
Hepatic failure associated with imipramine therapy. Pharmacotherapy (1990) 0.75
Tracheal invasion by thyroid carcinoma. Ear Nose Throat J (1990) 0.75
Endoscopy in the diagnosis of gastrointestinal Mycobacterium avium-intracellulare infection. J Clin Gastroenterol (1991) 0.75
A macro-driven Lotus 1-2-3 template for calculating and plotting receiver-operator characteristic curves for clinical laboratory tests. Comput Biol Med (1990) 0.75
EMIT quantitative tricyclic antidepressant assays applied to the Encore Chemistry System. Clin Chem (1987) 0.75
Pyrazolopyrimidine nucleosides. 3. Synthesis of 1- and 2-( -D-ribofuranosyl)pyrazolo(3,4-d)pyrimidines from pyrazole nucleoside derivatives. J Chem Soc Perkin 1 (1972) 0.75
Cyclosporine concentrations in blood after liver transplantation: correlation of immunoassay results with clinical events. Clin Chem (1989) 0.75
Mesenchymal chondrosarcoma: a case report. J Oral Maxillofac Surg (1987) 0.75
Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling. Nebr Med J (1989) 0.75
Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic. J Pharmacol Exp Ther (1993) 0.75
Development of squamous cell carcinoma of the esophagus after endoscopic variceal sclerotherapy. Am J Gastroenterol (1988) 0.75
The effects of dietary amino acids on hepatic L-asparagine synthetase. Metabolism (1984) 0.75
Partial purification and zinc dependence of human red cell pyrimidine-5'-nucleotidase. Enzyme (1983) 0.75
Abnormal erythrocyte pyrimidine nucleotides in uremic subjects. Nephron (1985) 0.75
Regulation of carbohydrate metabolism in mouse liver. Effect of glucagon on gluconeogenic/glycolytic flux in isolated perfused livers. Comp Biochem Physiol B (1979) 0.75
Hydralazine-induced cholestatic jaundice following liver transplantation. Transplantation (1989) 0.75
The correlation of mononuclear cell growth liver transplant biopsy cultures with histologic evidence of rejection and allograft dysfunction. Transplant Proc (1989) 0.75
Hepatic lipid peroxidation, sulfhydryl status, and toxicity of the blue-green algal toxin microcystin-LR in mice. J Toxicol Environ Health (1990) 0.75
Effect of pH and ions on the electronic structure of saccharin. Food Chem Toxicol (1987) 0.75
The spectrum of Epstein-Barr virus infection with hepatitis following liver transplantation. Transplant Proc (1991) 0.75
Induction of hyperplastic liver nodules in Wistar and MRC-Wistar rats by phenobarbital and the liver carcinogens acetoxime, 1-nitroso-5,6-dihydrouracil and 3-nitroso-2-oxazolidinone. Cancer Lett (1988) 0.75
Histologic changes in liver allograft biopsies associated with elevated whole blood and tissue cyclosporine concentrations. Mod Pathol (1992) 0.75
Bile duct hemorrhage: a biopsy finding after cholangiography or biliary tree manipulation. Liver (1992) 0.75